Your session is about to expire
← Back to Search
MicroRNA-210 Regulation for Peripheral Arterial Disease
Study Summary
This trial looks at the role of microRNA-210 in peripheral artery disease and potential treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I recently had a blood clot or injury affecting my leg.I am 30 years old or older.I have severe leg pain or non-healing wounds due to poor blood flow.I have been diagnosed with blockages in the arteries below my groin.I am considered a candidate for leg artery surgery by my vascular surgeon.I am expected to live less than 2 years because of conditions not related to PAD.I am currently undergoing chemotherapy or radiation therapy.I do not have arthritis, back pain, or sciatica.
- Group 1: Revascularization group
- Group 2: Control group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the estimated participation rate in this clinical trial?
"Affirmative, the information located on clinicaltrials.gov attests that this research endeavour is presently recruiting individuals to participate. This trial was introduced on September 15th 2019 and was recently updated in March 3rd 2022; it seeks 230 participants from two medical sites."
What are the essential goals of this experiment?
"This medical trial's primary outcome measure is the Change from baseline to six-month follow-up of Calf muscle biopsy biochemical measures. Secondary assessments include Graded treadmill walk performance (where patients must strive for a maximum distance while on an inclining treadmill), Walking Impairment Questionnaire (scoring 0 - 100, with higher scores being ideal) and 36 Item Short Form questionnaire (again scoring between 0 - 100)."
Are there any open enrollment opportunities for this clinical trial?
"Affirmative. Clinicaltrials.gov verifies that this clinical experiment, which was initially listed on September 15th 2019, is still actively recruiting participants. A total of 230 people need to be enrolled from 2 medical facilities."
Share this study with friends
Copy Link
Messenger